Cargando…
The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172478/ https://www.ncbi.nlm.nih.gov/pubmed/30306123 http://dx.doi.org/10.1016/j.jdcr.2018.08.027 |
| _version_ | 1783360954674708480 |
|---|---|
| author | Suresh, Raagini Murase, Jenny E. |
| author_facet | Suresh, Raagini Murase, Jenny E. |
| author_sort | Suresh, Raagini |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6172478 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61724782018-10-10 The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy Suresh, Raagini Murase, Jenny E. JAAD Case Rep Case Series Elsevier 2018-10-03 /pmc/articles/PMC6172478/ /pubmed/30306123 http://dx.doi.org/10.1016/j.jdcr.2018.08.027 Text en © 2018 Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Case Series Suresh, Raagini Murase, Jenny E. The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy |
| title | The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy |
| title_full | The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy |
| title_fullStr | The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy |
| title_full_unstemmed | The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy |
| title_short | The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy |
| title_sort | role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy |
| topic | Case Series |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172478/ https://www.ncbi.nlm.nih.gov/pubmed/30306123 http://dx.doi.org/10.1016/j.jdcr.2018.08.027 |
| work_keys_str_mv | AT sureshraagini theroleofexpandedseriespatchtestinginidentifyingcausalityofresidualfacialdermatitisfollowinginitiationofdupilumabtherapy AT murasejennye theroleofexpandedseriespatchtestinginidentifyingcausalityofresidualfacialdermatitisfollowinginitiationofdupilumabtherapy AT sureshraagini roleofexpandedseriespatchtestinginidentifyingcausalityofresidualfacialdermatitisfollowinginitiationofdupilumabtherapy AT murasejennye roleofexpandedseriespatchtestinginidentifyingcausalityofresidualfacialdermatitisfollowinginitiationofdupilumabtherapy |